Home > News > GMU scientists design nanoparticle for use in early disease detection
January 23rd, 2008
GMU scientists design nanoparticle for use in early disease detection
Abstract:
Scientists at George Mason University have developed a new technology to detect diseases such as cancer at an earlier stage than with standard testing methods.
They plan to take their innovation into the commercial market this year, followed by widespread distribution in physicians' offices.
Molecules in blood samples also start to degrade very quickly, which can change the biomarkers.
The team has designed smart hydrogel nanoparticles that can be mixed with blood samples. The particles "concentrate, capture, protect and preserve biomarkers," Liotta said.
A team at the university's Center for Applied Proteomics and Molecular Medicine has figured out a way to better identify biomarkers, which can indicate the presence of cancer, as well as cardiovascular and infectious diseases.
"The basic problem in biomarkers is that they're in very low concentration," said Dr. Lance Liotta, co-director of the center. A tiny tumor will produce a tiny amount of biomarkers that will be diluted in a blood sample.
Source:
examiner.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||